CDMO Profile

Upperton Pharma Solutions

Upperton Pharma Solutions Contract Manufacturing & Development (CDMO) Profile

Upperton Pharma Solutions is a UK-based leading contract development and manufacturing organisation (CDMO) specialising in formulation development, clinical trial manufacturing and manufacturing services for a wide range of dosage forms, including oral solids, liquids, semi-solids, and inhalation products. With state-of-the-art facilities and a team of experienced scientists, Upperton offers tailored solutions to accelerate drug development from concept to commercialisation. A King’s Award For Enterprise winner, Upperton is committed to innovation, and quality, and share in our customers’ dedication to changing patients’ lives. Upperton collaborates closely with global pharmaceutical and biotech companies to bring novel therapies to market efficiently and effectively.

CDMO Services:
Finished Dosage Forms (Small Molecule Drugs); Biologics Cartridges; Inhalers; Liquids; Lyophilized amps/vials; Pre-Filled Syringes (PFS); Semi-solids; Solids; Sterile Ampoules; Sterile Vials Analytical Development; Drug Delivery System; Formulation Development; ICH Stability Testing; Process Development

Year Founded: 1999

Head Office: Nottingham, United Kingdom

Number of Facilities: 1-2

Facility locations: Europe

Website: Visit the Upperton Pharma Solutions website

Linkedin: Connect on Linkedin

Sign up to the free weekly newsletter for all the latest news, resources and podcasts in contract manufacturing.  Register here

Experience the future of contract manufacturing

Join us at CDMO Live, 7-8 May 2025 in Rotterdam for an exclusive live event dedicated to contract manufacturing partnerships. Apply for your ticket.

INFOGRAPHIC

Download the latest infographic summarising key players in Small Molecule, Biologics and Cell & Gene Therapies.

Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.